Cancer Biosimilars-A Regulatory Success So Far, but Value Still to Be Determined. JAMA oncology Blayney, D. W., Silver, S. M. 1800

View details for DOI 10.1001/jamaoncol.2021.6979

View details for PubMedID 35113156